PHARMAC and erythropoietin for cancer patients

N Z Med J. 2006 Jun 23;119(1236):U2039.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anemia / drug therapy*
  • Anemia / etiology*
  • Cost-Benefit Analysis
  • Drug and Narcotic Control*
  • Erythropoietin / economics*
  • Erythropoietin / therapeutic use*
  • Evidence-Based Medicine / methods
  • Humans
  • National Health Programs / economics
  • Neoplasms / complications*
  • New Zealand
  • Treatment Outcome

Substances

  • Erythropoietin